Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy

出版年份 2019 全文链接

标题

作者

关键词

出版物

Volume 37, Issue 9, Pages 693-702

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2019-02-07

DOI

10.1200/jco.18.01896

Discuss science. Find collaborators. Network.

Join a conversation

Explore over 38,000 international journals covering a vast array of academic fields.